ÂÜÀòÂÒÂ×

Ernst Kriehuber has extensive experience in translational medicine, focusing on dermatology, rheumatology, neurology, and oncology populations. Ernst has held various leadership positions in reputable pharmaceutical companies such as UCB, Glenmark Pharmaceuticals, and Novartis Institutes for BioMedical Research, where Ernst led teams in early clinical development and translational research. With a background in medical research and a Doctor of Medicine degree from the Medical University of Vienna, Ernst has demonstrated expertise in immune-mediated diseases and oncology.